The recruitment of CARM1 to the ERα target promoters is dependent on nuclear receptor coactivator 3 (NCOA3; also known as steroid receptor coactivator-3, SRC-3), which is overexpressed in aggressive breast cancers together with CARM139. Here, NCOA3 is linked to breast carcinoma.